Clinical Trial Site Monitoring for PHOENIx MDR-TB

PHOENNIx 耐多药结核病临床试验现场监测

• 批准号: 10818317
• 负责人: KIMBERLY SMITH
• 金额: $ 92.99万
• 依托单位: PPD DEVELOPMENT LP
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-04-15 至 2024-04-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10818317
• 关键词: AIDS clinical trial group; Acquired Immunodeficiency Syndrome; Adult; Clinical Research; Clinical Trials; Clinical Trials Network; Exposure to; HIV; Household; International; International Maternal Pediatric Adolescent AIDS Clinical Trials; Mission; Monitor; Multicenter Trials; Multidrug-Resistant Tuberculosis; National Institute of Allergy and Infectious Disease; Newly Diagnosed; Patients; Phase; Phase III Clinical Trials; Probability; Research Support; Resources; Safety; Services; Site; Time; United States Dept. of Health and Human Services; United States National Institutes of Health; clinical research site; comparative efficacy; global health; high risk; indexing; isoniazid; open label; prevent

The National Institute of Allergy and Infectious Diseases (NIAID), Division of Clinical Research (DCR), rapidly deploys administrative and technical research support services and resources to meet the external demands placed on the NIAID to conduct time sensitive, high priority, global, collaborative clinical research critical to the mission of the NIAID and advancement of the National Institutes of Health (NIH) and Department of Health and Human Services (DHHS) Global Health Agendas. Fulfillment of this mission requires DCR to have the capacity to expeditiously facilitate collaborative clinical research both domestically and internationally.

美国国家过敏症和传染病研究所 (NIAID) 临床研究部 (DCR) 快速部署行政和技术研究支持服务和资源，以满足 NIAID 开展时间敏感、高度优先、全球性、协作性临床研究的外部需求，这对 NIAID 的使命以及美国国立卫生研究院 (NIH) 和卫生与公众服务部 (DHHS) 全球健康的进步至关重要 议程。完成这一使命需要 DCR 有能力迅速促进国内和国际合作临床研究。